Skip to main content
. 2023 Dec 5;15(24):5015. doi: 10.3390/nu15245015

Table 3.

Safety assessment of WS supplementation.

Study Safety Assessment Adverse Events (AEs) Subjects with AEs (%)
1 [34] Yes Mild 20%
2 [35] Yes Mild 4%
3 [36] Yes None 0%
4 [42] No ---- ----
5 [37] Yes None 0%
6 [41] Yes None 0%
7 [38] No ---- ----
8 [39] No ---- ----
9 [40] Yes None 0%